Preparation of self-assembly silica redox nanoparticles to improve drug encapsulation and suppress the adverse effect of doxorubicin

BACKGROUND AND PURPOSE: The utilization of doxorubicin (DOX) in clinal trials is also challenging owing to its adverse effects, including low oral bioavailability, generation of reactive oxygen species (ROS), cardiotoxicity, and epithelial barrier damage. Recently, scavenging of ROS reduced the cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Minh-Dat Quoc, Trinh, Nhu-Thuy, Vu, Dung, Nguyen, Thu-Ha Thi, Dong, Hung Thanh, Vo, Toi Van, Vong, Long Binh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Association of Physical Chemists 2023
Materias:
Original Scientific Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626516/
https://www.ncbi.nlm.nih.gov/pubmed/37937241
http://dx.doi.org/10.5599/admet.1845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626516/
https://www.ncbi.nlm.nih.gov/pubmed/37937241
http://dx.doi.org/10.5599/admet.1845

Ejemplares similares